Pharmaceuticals & Life Sciences

UI/UX Design for Pharmaceuticals & Life Sciences

UI/UX Design for pharmaceuticals & life sciences, built around the constraint that defines the sector: GxP validation means every system change needs documented evidence before it reaches production.

Regulations in scope
5
Systems we integrate
5
Typical first release
6 weeks

What changes when it is pharmaceuticals & life sciences

Accessibility built in costs almost nothing; retrofitted it costs a rewrite. Colour contrast, focus states and touch targets are not a late-stage audit item.

In pharmaceuticals & life sciences, GxP validation means every system change needs documented evidence before it reaches production. That single fact reshapes how ui/ux design has to be built here, the guardrails, the approval points and the evidence trail are design inputs rather than things bolted on before go-live.

The workload we are most often asked to take on first is regulatory dossier assembly, usually integrated against SAP. We build the smallest thing that proves the case, put it in front of real users, and expand only what earns its keep.

Built by engineers who ship production systems, not by a practice that subcontracts the build. Six weeks to something running in production, not six quarters to a strategy document.

The sector constraints we design around

Defining constraint
GxP validation means every system change needs documented evidence before it reaches production
Regulations in scope
CDSCO · US FDA 21 CFR Part 11 · EU GMP Annex 11 · GxP validation · ICH guidelines
Systems of record
LIMS · QMS · eTMF · SAP · pharmacovigilance databases
Where we usually start
batch record review

UI/UX Design workloads in pharmaceuticals & life sciences

  • batch record review
  • adverse event intake and coding
  • regulatory dossier assembly
  • deviation and CAPA drafting
  • literature monitoring

What is included

  • User research proportionate to the risk, interviews, not assumptions
  • Information architecture and user flows before any visual work
  • Wireframes and interactive prototypes for testing cheaply
  • Visual design in a system, not as one-off screens
  • Usability testing with real users from your actual audience
  • Developer-ready handoff with specs, tokens and states

Questions from this sector

Can an AI system be GxP validated?

Yes, with a documented validation approach, IQ/OQ/PQ, defined intended use, change control and evidence of consistent performance. We build the validation pack alongside the system, not afterwards.

How do you handle 21 CFR Part 11?

Audit trails, electronic signatures, access control and record integrity designed in from the start, because retrofitting them is effectively a rebuild.

What is the difference between UI and UX?

UX is how it works, flows, structure, whether someone can finish the task. UI is how it looks and responds. A beautiful interface over a confused flow still fails, which is why the flow comes first.

Do we need user research?

Proportionate to the risk. A handful of interviews before committing engineering months is cheap insurance; for a small internal tool it may be overkill, and we will say so.

Will developers be able to build it?

Yes, handoff includes specs, tokens, component states and edge cases. Designs that ignore loading, empty and error states are the usual source of build friction.

UI/UX Design for pharmaceuticals & life sciences, worth a conversation?

Tell us the workload and the regulation it sits under. We will tell you what is realistic.

Or email bd@dtrasglobal.com · call +91 74118 77878